GlassScriptPhysician profile
Heather R Williams
NPI 1316937022
$1,327.94
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $141 · 2021: $191 · 2022: $506 · 2023: $189 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.27 | 2020-2023 | Liletta |
| Organon LLC | $221.39 | 2022-2024 | Nexplanon |
| Avion Pharmaceuticals | $110.73 | 2019-2022 | |
| Meditrina | $104.12 | 2022 | |
| Axonics, INC. | $94.36 | 2023 | Bulkamid |
| Evofem Biosciences, INC. | $70.32 | 2022-2023 | Phexxi |
| Scynexis, INC. | $56.26 | 2022 | |
| Hologic Sales and Service, LLC | $56.14 | 2019-2021 | |
| Duchesnay USA Incorporated | $50.61 | 2019 | |
| Lupin INC. | $43.31 | 2019-2020 | |
| Baxter Healthcare | $28.94 | 2022 | |
| Therapeuticsmd, INC. | $24.38 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $24.07 | 2021 | |
| Astellas Pharma US INC | $23.31 | 2020 | |
| Roche Diagnostics Corporation | $19.79 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $18.08 | 2022 | |
| Merck Sharp & Dohme LLC | $17.70 | 2021 | |
| Becton, Dickinson and Company | $16.53 | 2022 | |
| Covidien LP | $14.57 | 2019 | |
| Agile Therapeutics, INC. | $12.06 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.